Spun-out out of the University of Alabama at Birmingham and also licensing the underlying technology form that instiution, Reliant Glycosciences LLC is a biotech firm developing diagnostic and prognostic tools for patients with IgA nephropathy. A chronic kidney disease often progressing to renal failure, there is no disease-specific treatment of afflicted patients. Radiant Glycosciencesis is structured around developing assays for biomarkers of IgA nephropathy with diagnostic and/or prognostic value that would enable development and testing of future disease-specific therapies. The defined objective is thatthe firm's biomarker assays will provide an avenue for early identification of patients with IgA nephropathy. That c/would enable development of successful treatment options while also providing a tool to monitor responses to therapy.
